Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-09-28 | Ms. Brennan was appointed to the Board effective September 6, 2022 under the Cooperation Agreement. She held various positions at Johnson & Johnson and brings substantial experience in healthcare, regulatory compliance, manufacturing operations, strategy, finance, and international markets. |
| 2023-09-27 | Michelle M. Brennan Age 58 Director since: 2022 Independent Director Board Committees: Audit, Human Resources and Compensation Value Creation Leader of Johnson & Johnson (retired) |
| 2024-09-16 | Ms. Brennan brings to the Board substantial experience in the areas of healthcare, regulatory compliance, manufacturing operations, product quality, strategy, finance, and international markets. She also brings to the Board valuable perspectives and insights from her service on the Masimo board and her prior service on the Coupa Software board, but no direct software engineering or programming experience is indicated. |
Data sourced from SEC filings. Last updated: 2025-08-30